What is anemia?
Causes and risk factors of iron deficiency anemia
When we look at the causes of iron deficiency anemia, we can count three main causes; inadequate intake of iron from food, conditions with iron malabsorption (imperfect absorption), and iron loss more than iron intake.
In adults in developed countries, dietary intake is usually adequate and it is important to assume that the cause is blood loss until proven otherwise and to investigate this as a priority. However, this is not the case for underprivileged populations. As in the diagnosis of many diseases, a good history is the most important factor in determining the cause of iron deficiency anemia. Nutritional status, the presence of diarrhea in terms of possible malabsorption, previous gastrointestinal surgery, medications, and the presence of any bleeding foci should be questioned in detail.
Reduced iron absorption
Iron is absorbed in the upper gastrointestinal tract, with the duodenum being the site of highest absorption [3]. Reduced iron absorption is a rare cause of iron deficiency, especially in healthy individuals and in parts of the world where there is access to an iron-rich diet.
Disorders affecting mucosal cells responsible for iron absorption such as celiac disease, atrophic (autoimmune*) gastritis, Helicobacter pylori infection, and bariatric surgery (surgery for obesity that cannot be treated with diet and exercise) are important causes of malabsorption (imperfect absorption).
In people with gastrointestinal symptoms or inadequate response to oral iron supplementation, sources of reduced iron absorption may be considered. A source of bleeding should be excluded, whether or not reduced iron absorption has been documented.
*Autoimmune: A situation in which a person creates an immune response against his or her own cells and tissues as a result of a disorder in the immune system.
Dietary
Heme iron (iron from meat rather than plant sources) is better absorbed than non-heme iron, but both sources are important. A review of published studies assessing vegetarians and non-vegetarians found that those who consumed a vegetarian diet were more likely to develop iron deficiency.
Some foods can impair iron absorption, such as tannins (found in tea), phosphates, phytates (mineral-binding compounds found in whole grains and seeds), and foods high in calcium.
One case report described iron deficiency in an individual who drank excessive amounts of tea (more than 1500 mL per day for 20 years). Upper and lower endoscopies showed no pathological conditions and hemoglobin increased with cessation of tea drinking and decreased with continued tea drinking.
Celiac disease (gluten-sensitive enteropathy)
Celiac disease (gluten-sensitive enteropathy) is a small intestinal malabsorption disorder triggered by exposure to gluten in susceptible individuals. Iron may contribute to anemia through several mechanisms, including malabsorption (imperfect absorption) of other nutrients required for red blood cell (RBC) production, including vitamin B12, folic acid, and copper.
Autoimmune gastritis or Helicobacter pylori
Autoimmune gastritis or Helicobacter pylori (H. pylori); gastritis due to an autoimmune mechanism (e.g., anti-parietal cell antibodies) or H. pylori has also been shown to be an important cause of iron deficiency.
Bariatric surgery
Iron requires to be conjugated with vitamin C, amino acids, or sugars in the presence of gastric acid to protect it from alkaline (in a base pH) secretions in the proximal jejunum; otherwise, iron is converted to ferric hydroxide and cannot be absorbed. Bariatric surgery involves a number of procedures that promote weight loss by limiting the reservoir capacity of the stomach and/or shortening the length of the functional small intestine, leading to malabsorption (imperfect absorption). The risk of causing iron deficiency is highest as it reduces the absorption area. Monitoring iron status is recommended after most bariatric surgeries with routine iron supplementation or iron supplementation as needed.
Drugs
An acidic gastric environment facilitates the absorption of iron, especially non-heme iron. Reduced gastric acidity alone is unlikely to cause clinically significant iron deficiency in an individual with adequate dietary iron intake and a normally functioning gastrointestinal tract.
Drugs that reduce gastric acidity, especially proton pump inhibitors (PPIs, stomach protector), have been suggested to decrease iron absorption.
Inherited disorders that interfere with iron absorption
Inherited disorders that interfere with iron absorption are very rare. IRIDA (iron therapy-resistant iron deficiency anemia) due to a TMPRSS6 mutation is a rare inherited disorder in which oral iron absorption is markedly impaired. IRIDA is caused by loss-of-function mutations of the TMPRSS6/matriptase 2 gene, which encodes a serine protease that cleaves membrane-bound hemojuvelin. It causes iron deficiency due to inappropriately high levels of hepcidin, markedly decreased iron absorption, and increased iron uptake in macrophages*. Patients present with mild hypochromic*, microcytic anemia*** with very low serum iron levels and low transferrin saturation. Serum ferritin levels are usually in the normal range or slightly elevated following intravenous iron therapy.
*Macrophage: These are white blood cells that protect the body against diseases.
**Hypochromia: The amount of hemoglobin in the red blood cell is below the reference range of 32 - 36 grams/deciliter (g/dL).
***Microcytic anemia: It suggests a type of anemia in which red blood cells are smaller than normal.
Iron deficiency anemia due to iron loss
Menstrual bleeding is the most important cause of iron deficiency anemia in premenopausal women. Gastrointestinal bleeding in postmenopausal women and adult men is an important cause of IDA. Further investigations are absolutely necessary. Upper and lower gastrointestinal endoscopy is recommended to rule out the bleeding focus and possible malignancy (types of tumors that can be considered cancer). Bleeding disorders such as Von Willebrand Disease should also be kept in mind, especially in prolonged menstrual bleeding.
Symptoms of anemia
Symptoms of anemia
In individuals with iron deficiency (regardless of the presence of anemia), physical examination may appear normal. However, one or more of the following clinical signs may be observed:
-
Pale skin
-
Dry or rough skin
-
Atrophic glossitis (inflammation of the tongue) with loss of lingual papillae, often accompanied by tongue pain and dry mouth
-
Cheilosis (cracks at the corners of the mouth)
-
Koilonychia (spoon-shaped nails)
-
Esophageal web (thin membranes that can appear anywhere along the esophagus), which may be associated with dysphagia (difficulty swallowing)
-
Hair loss
Treatment
1. Ferhanoğlu B. PDQ Hematology (William F.Kern, MD). 1st EditionIstanbul Medical Publishing, 2005: 1-155
2. Ünal S. Cecil Texbook of Medicine (L. Goldman, D. Ausiello). 22nd Edition. Güneş Publishing House, 2006:963-75
3. Schröder O, Mickisch O, Seidler U, et al. Oral iron supplementation versus intravenous iron sucrose in the treatment of iron deficiency anemia in patients with inflammatory bowel disease - a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005; 100:2503.
4. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13:1545.
5. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13:1545.
6. Reinisch W, Chowers Y, Danese S, et al. The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method. Aliment Pharmacol Ther 2013; 38:1109.Gasche C, Evstatiev R, Haas T, et al. [Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party]. Z Gastroenterol 2011; 49:627
7. Mamula P, Piccoli DA, Peck SN, et al. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002; 34:286.
8. Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44:838.
9. Kim YW, Bae JM, Park YK, et al. Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial. JAMA 2017; 317:2097.
10. Auerbach M, Achebe MM, Thomsen LL, Derman RJ. Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery. Obes Surg 2022; 32:810.
11. Khalafallah AA, Yan C, Al-Badri R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol 2016; 3:e415.
12. Hershko C, Ronson A. Iron deficiency, Helicobacter infection and gastritis. Acta Haematol 2009; 122:97.
13. Auerbach M, Liang AS, Glaspy J. Intravenous iron in chemotherapy and cancer-related anemia. Community Oncol 2012; 9:289.
14. Gafter-Gvili A, Rozen-Zvi B, Vidal L, et al. Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials. Acta Oncol 2013; 52:18.
15. Rodgers GM 3rd, Becker PS, Blinder M, et al. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw 2012; 10:628.
16. Kim YT, Kim SW, Yoon BS, et al. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol 2007; 105:199.
17. Dangsuwan P, Manchana T. Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol 2010; 116:522.
18. Steinmetz T, Tschechne B, Harlin O, et al. Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. Ann Oncol 2013; 24:475.
19. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood 2002; 100:4272.
20. Clénin G, Cordes M, Huber A, et al. Iron deficiency in sports - definition, influence on performance and therapy. Swiss Med Wkly 2015; 145:w14196.
21. Alaunyte I, Stojceska V, Plunkett A. Iron and the female athlete: a review of dietary treatment methods for improving iron status and exercise performance. J Int Soc Sports Nutr 2015; 12:38.
22. Tolkien Z, Stecher L, Mander AP, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One 2015; 10:e0117383.
23. Bregman DB, Morris D, Koch TA, et al. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 2013; 88:97
24. Werner E, Kaltwasser JP, Ihm P. [Oral iron treatment: intestinal absorption and the influence of a meal (author's transl)]. Dtsch Med Wochenschr 1977; 102:1061
25. . Bazeley JW, Wish JB. Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review. Am J Kidney Dis 2022; 79:868.
26. Powers JM, Buchanan GR, Adix L, et al. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial. JAMA 2017; 317:2297.
27. Lee T, Clavel T, Smirnov K, et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut 2017; 66:863.
28. Cook JD, Reddy MB. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr 2001; 73:93.
29. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, et al. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin 2013; 29:291.
30. Macdougall IC, Strauss WE, McLaughlin J, et al. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. Clin J Am Soc Nephrol 2014; 9:705.